The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

This Week in the Twitterverse

Here’s some weekend reading from our Twitter stream on @crossborderbio …

  • Friday Science Review is back, thx to Mark Curtis! Today’s cool Canadian science = tomorrow’s cool startups…
  • DTC genetics link in last tweet is from @CMAJ_News – also contrasts Class III regulation of companion diagnostics. I.e. DTC is non-clinical?
  • MT @genomicslawyer: …Health Canada is taking a “far more relaxed approach” than U.S. regulators to DTC genetics
  • RT @JohnCFierce: Covance is buying 3 R&D facilities from sanofi and inked a 10-yr research contract worth up to $2.2B
  • RT @MSBiV: Leap Medical completes second tranche of financing a @McGillU spin-off and @MSBiV investee
  • Planning to! RT @robannan: I’m going – anyone else? RT @JVPLS @sciencepolicy Canadian Science Policy Conf Mtl Oct.20-22
  • Biovail, Valeant shareholders vote to approve merger, expected to close tomorrow.
  • RT @MaRSDD: Blog – Got a management challenge? Win a ticket to see Malcolm Gladwell! …
  • RT @genomicslawyer: BGI as one of China’s multiple “moon shots”, as told by Thomas Friedman of NYT: H/T @phylogenomics
  • Happy Bday! RT @IlseTreurnicht: Birthday cake @MaRSDD: 5 years since opening of the MaRS Centre today…
  • Healthcare giving down in the U.S. and up in Canada (2008 vs 2009, tho 2009 in Canada just = recovery to 2006 levels)

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


Get every new post delivered to your Inbox.

Join 128 other followers